Bielekova, Bibiana
Wu, Tianxia
Kosa, Peter
Calcagni, Michael
Funding for this research was provided by:
National Institute of Allergy and Infectious Diseases (AI001242-07)
National Institute of Allergy and Infectious Diseases
Article History
Received: 6 August 2025
Accepted: 22 December 2025
First Online: 10 January 2026
Declarations
:
: The natural history protocol “Comprehensive Multimodal Analysis of Neuroimmunological Diseases of the Central Nervous System” (clinicaltrials.gov identifier NCT00794352) is approved by the Institutional Review Board of the National Institutes of Health (last annual review: protocol 09-I-0032: CR003273 approved 7/1/2025).All participants in the independent validation cohort signed the informed consent before participating.
: The contributions of the NIH author(s) were made as part of their official duties as NIH federal employees and are considered Works of the United States Government. NIH policy requires public access without embargo and supports open publications.
: The authors declare no competing interests.